Search research articles
Contact Us
Filters
Showing results (191-200 of 311) with videos related to
Page
of 32
Sort By:
Diabetes, Obesity & Metabolism
|
August 4, 2016
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials
Henry Ginsberg, Bertrand Cariou, Trevor Orchard, et al.
Diabetes Care
|
June 26, 2018
HbA<sub>1c</sub> and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Thomas Danne, Bertrand Cariou, Phillip Banks, et al.
Diabetes Care
|
March 6, 2019
Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Thomas Danne, Bertrand Cariou, John B Buse, et al.
Journal of Diabetes and Its Complications
|
June 9, 2016
Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials
Daisuke Yabe, Anu Ambos, Bertrand Cariou, et al.
Cardiovascular Diabetology
|
June 10, 2022
Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort
Matthieu Wargny, Mikaël Croyal, Stéphanie Ragot, et al.
Cardiovascular Diabetology
|
February 10, 2020
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
Helen M Colhoun, Lawrence A Leiter, Dirk Müller-Wieland, et al.
Plos One
|
July 23, 2013
A standardized vascular disease health check in europe: a cost-effectiveness analysis
C Andy Schuetz, Peter Alperin, Swathi Guda, et al.
Diabetes Care
|
August 28, 2020
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
Matthieu Wargny, Pierre Gourdy, Lisa Ludwig, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 18, 2020
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes
Mikael Croyal, Pierre-Jean Saulnier, Audrey Aguesse, et al.
Diabetes Technology & Therapeutics
|
July 24, 2019
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes
Thomas Danne, Jeremy Pettus, Andrea Giaccari, et al.
Page
of 32
Search research articles
Search
Showing results (191-200 of 311) with videos related to
Sort By:
Page
of 32
Diabetes, Obesity & Metabolism
|
August 4, 2016
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials
Henry Ginsberg, Bertrand Cariou, Trevor Orchard, et al.
Diabetes Care
|
June 26, 2018
HbA<sub>1c</sub> and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Thomas Danne, Bertrand Cariou, Phillip Banks, et al.
Diabetes Care
|
March 6, 2019
Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Thomas Danne, Bertrand Cariou, John B Buse, et al.
Journal of Diabetes and Its Complications
|
June 9, 2016
Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials
Daisuke Yabe, Anu Ambos, Bertrand Cariou, et al.
Cardiovascular Diabetology
|
June 10, 2022
Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort
Matthieu Wargny, Mikaël Croyal, Stéphanie Ragot, et al.
Cardiovascular Diabetology
|
February 10, 2020
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
Helen M Colhoun, Lawrence A Leiter, Dirk Müller-Wieland, et al.
Plos One
|
July 23, 2013
A standardized vascular disease health check in europe: a cost-effectiveness analysis
C Andy Schuetz, Peter Alperin, Swathi Guda, et al.
Diabetes Care
|
August 28, 2020
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
Matthieu Wargny, Pierre Gourdy, Lisa Ludwig, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 18, 2020
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes
Mikael Croyal, Pierre-Jean Saulnier, Audrey Aguesse, et al.
Diabetes Technology & Therapeutics
|
July 24, 2019
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes
Thomas Danne, Jeremy Pettus, Andrea Giaccari, et al.
Page
of 32